Publication:

Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2 (2010)

Author(s): Walter MC, Czemin B, Muller-Ziermann S, Bulst S, Stewart JD, Hudson G, Schneiderat P, Abicht A, Holinski-Feder E, Lochmuller H, Chinnery PF, Klopstock T, Horvath R

    Abstract: Polymerase gamma 1 (POLG) mutations are a frequent cause of both autosomal dominant and recessive complex neurological phenotypes. In contrast, only a single pathogenic mutation in one patient was reported in POLG2 so far. Here we describe a 62-year-old woman, carrying a novel heterozygous sequence variant in the POLG2 gene. She developed bilateral ptosis at 30 years of age, followed by exercise intolerance, muscle weakness and mild CK increase in her late forties. Muscle histology and respiratory chain activities were normal. Southern blot and long range PCR detected multiple mtDNA deletions, but no depletion in muscle DNA. Sequencing of POLG, PEO1, ANT1, OPA1 and RRM2B showed normal results. A novel heteroallelic 24 bp insertion (c.1207_1208ins24) was detected in POLG2. This 24 bp insertion into exon 7 causes missplicing and loss of exon 7 in myoblast cDNA. We did not detect POLG2 mutations in 62 patients with multiple mtDNA deletions in muscle DNA, suggesting that POLG2 mutations may represent a rare cause of autosomal dominant PEO.

      • Date: 20-04-2010
      • Journal: Journal of Neurology
      • Volume: 257
      • Issue: 9
      • Pages: 1517-1523
      • Publisher: Dr. Dietrich Steinkopff Verlag
      • Publication type: Article
      • Bibliographic status: Published

      Keywords: Ptosis - Mitochondrial myopathy - mtDNA deletions - Polymerase gamma 2 (POLG2)

      Staff

      Professor Patrick Chinnery
      Institute Director

      Dr Gavin Hudson
      Research Fellow